Director/PDMR Shareholding
Arix Bioscience plc
Director/PDMR Shareholdings
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Robert Lyne | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CEO and General Counsel | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name
| Arix Bioscience plc | |||
b)
| LEI
| 213800OVT3AHQCXNIX43
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | |||
Identification code | GB00BD045071 | ||||
b)
| Nature of the transaction
| Share purchase | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
120.00p | 41,666.00 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A single transaction | ||||
- Price | £49,999.20 | ||||
e)
| Date of the transaction
| 16 December 2021 | |||
f)
| Place of the transaction
| London Stock Exchange |
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Peregrine Moncreiffe | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Non-Executive Director and Chair of the Board | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name
| Arix Bioscience plc | |||
b)
| LEI
| 213800OVT3AHQCXNIX43
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | |||
Identification code | GB00BD045071 | ||||
b)
| Nature of the transaction
| Share purchase | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
119.00p | 84,000.00 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A single transaction | ||||
- Price | £99,959.98 | ||||
e)
| Date of the transaction
| 16 December 2021 | |||
f)
| Place of the transaction
| London Stock Exchange |
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Sir Michael Bunbury | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Non-Executive Director and Senior Independent Director (SID) | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name
| Arix Bioscience plc | |||
b)
| LEI
| 213800OVT3AHQCXNIX43
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | |||
Identification code | GB00BD045071 | ||||
b)
| Nature of the transaction
| Share purchase | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
119.00p | 40,000.00 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A single transaction | ||||
- Price | £47,600.00 | ||||
e)
| Date of the transaction
| 16 December 2021 | |||
f)
| Place of the transaction
| London Stock Exchange |
For further information please contact:
Derringtons Limited, Company Secretary
+44 20 8819 6486
Ends.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.